期刊文献+

地中海饮食对肺癌相关性影响的研究进展

Research Progress of the Effect of Mediterranean Diet on the Correlation of Lung Cancer
下载PDF
导出
摘要 肺癌是当今世界十大死因之一,它以其高死亡率令全世界深感忧愁。在现代医学研究中,研究人员正致力于深入挖掘肺癌发生和发展的不同影响因素,以降低其发病率,提高肺癌的治疗成功率,改善肺癌患者的预后。地中海饮食(Mediterranean diet,MD)是一种特殊的膳食结构,它以吃蔬菜、水果、粗粮、豆类和低脂鱼类为主,被报道具有抗炎、抗氧化、降脂等作用。近年来的研究发现,MD可能会在一定程度上预防肺癌,并对其发病和进展产生重要影响。本文旨在对相关文献进行综述,总结及分析性地探讨MD对肺癌发病及进展的影响,从而更好地为预防和治疗肺癌提供研究方向。 Lung cancer is one of the top 10 causes of death in the world today,and it is a great concern worldwide for its high mortality rate.Currently,the researchers are digging into various factors influencing the occurrence and develop�ment of lung cancer in order to increase the odds for curing lung cancer,improve the prognosis of lung cancer patients as well as reduce its morbidity.The Mediterranean diet(MD)is a special dietary structure that is based on eating vegetables,fruits,coarse grains,legumes and low-fat fish,which have anti-inflammatory,antioxidant and lipid-lowering effects.Recent studies have revealed that the MD may prevent lung cancer occurrence to some extent and inhibit its development.The purpose of this paper is to summarize and analytically discuss the effects of the MD on the oncogenesis and development of lung cancer through a review of the relevant literatures,thus to provide references for MD to prevent and treat lung cancer.
作者 高明朗 赖凯 卢子龙 刘毅 李宁 耿庆 Minglang GAO;Kai LAI;Zilong LU;Yi LIU;Ning LI;Qing GENG(Department of Thoracic Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,China)
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2024年第4期299-305,共7页 Chinese Journal of Lung Cancer
基金 中央高校基本科研专项基金(No.2042021kf0081) 湖北省自然科学基金创新群体项目(No.2020CFA027)资助。
关键词 肺肿瘤 地中海饮食 饮食 健康 蔬菜 水果 Lung neoplasms Mediterranean diet Diet Health Vegetables Fruits
  • 相关文献

参考文献7

二级参考文献42

  • 1李殿鑫,陈银基,周光宏,徐幸莲.n-3多不饱和脂肪酸分类、来源与疾病防治功能[J].中国食物与营养,2006,12(6):52-54. 被引量:41
  • 2徐莉,王若兰,孙海燕.橄榄油储藏稳定性研究[J].食品科技,2007,32(1):182-185. 被引量:16
  • 3Harari PM, Huang SM. Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development. Semin Radiat Oncol,2002, 12(Suppl 2): 21-26.
  • 4Tang Z, Du R, Jiang S, et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. Br J Cancer, 2008,99(6): 911-922.
  • 5Das AK, Chen BP, Story MD, et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res, 2007,67(11): 5267-5274.
  • 6Safe S, Papineni S, Chintharlapalli S. Cancer chemotherapy with indole-3- carbinol, bis (3'-indolyl) methane and synthetic analogs. Cancer Lett, 2008, 269(2): 326-338.
  • 7Mao Y, Wu J, Skog S, et al. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and eDNA profiling. Oncol Rep, 2005,13(5): 837-846.
  • 8Kim YH, Ishii G, Goto K, et al. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Lung Cancer, 2009, 65( 1): 105-111.
  • 9Rosell R, Perez-Roca L, Sanchez JJ, et al. Customized treatment in nonsmall-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression. PLoS One, 2009, 4( 5): e5133.
  • 10Boukovinas I, Papadaki C, Mendez P, et al. Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients. PLoS One, 2008,3(11): e3695.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部